Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 8-K Event Shareholder vote results · Other events
  11. 8-K Event Other events
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 424B5 Offering Prospectus
  15. ARS Other Annual Report to Security Holders
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. SC 13G/A Stake Amended Statement of Ownership

Page 9 of 21 · 412 filings